Mutations in MTND6 are associated with an increase in metastatic potential that was associated with low NADH and high reactive oxygen species (ROS) in lung and breast cancer cell lines65,66 and heptatocellular carcinoma67. Here, MT-ND6 is linked to breast carcinoma.